I last reviewe d Veeva Systems (NYSE: VEEV ) shares at the start of this year. The shares have done well over that time, rising more than 30%. The question now is does theBert Hochfeld graduated with a degree in economics from the University of Pennsylvania and received an MBA from Harvard. Mr. Hochfeld has enjoyed a long career in the tech world, working for IBM, Memorex/Telex, Raytheon Data Systems, and BMC Software. Starting in the 1990s, Mr. Hochfeld worked as a sell-side analyst and won awards from the ...

Jabil’s NYSE: JBL share price struggled with traction early in 2025, but the struggles are behind it. The Q3 results and guidance update reveal the long-anticipated boost from AI is here. The company cited strengths in the cloud, data center infrastructure, and capital equipment segments, along with improved guidance, indicating that these strengths will continue. Jabil TodayJBLJabil$196.42 +15.60 (+8.63%) 52-Week Range$95.85▼$203.90Dividend Yield0.16%P/E Ratio46.99Price Target$169.17Add to WatchlistAmong ...

2025年06月18日 证券研究报告 | 在线音乐行业深度解析 复杂投资环境下的优质长期现金流资产 行业研究 · 海外市场专题 互联网 · 互联网Ⅱ 投资评级：优于大市（维持） 证券分析师：张伦可 证券分析师：陈淑媛 0755-81982651 021-60375431 zhanglunke@guosen.com.cn chenshuyuan@guosen.com.cn S0980521120004 S0980524030003 2 ü Spotify股价：23年为公司利润释放拐点，验证商业模式的长期可持续性，推动估值抬升。19-22年是Spotify "投资年" ，播客业 务等的投资导致亏损加大，23年开始更加关注降本增效以实现经营杠杆，24年公司首次实现全年盈利。Spotify后续驱动：1）全球 化发展，月活用户数仍有较大提升空间。2）随着音乐平台内容不断完善，平台议价能力增加，版权等成本有优化。当前Spotify VIP提价顺利，ARRPU值持续增长。25年开始公司继续发展超级VIP。 ü 腾讯音乐股价：订阅业务发展是主要驱动。21年以来，国内独家版权取消以及短视频行业发展倒逼音乐平台聚焦音乐主业。20 ...

Top-line results expected July 2025 as development of first-in-class OSA drug advancesNEW YORK and MELBOURNE, Australia, June 18, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, is pleased to announce that it has achieved database lock for the RePOSA Phase 2 clinical trial of IHL-42X, its lead drug candidate for obstructive sleep apnoea (OSA), on schedu ...

$1.5 million contract builds on ten-year relationship with Del NorteRESTON, Va., June 18, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, has been selected as the lead engineer for a $24 million municipal water system upgrade in the Town of Del Norte, Colorado—the town’s largest water infrastructure project to date. Under a $1.5 million contract, Bowman will deliver full design, construction administration and inspection serv ...

CHARLOTTE, N.C., June 18, 2025 /PRNewswire/ -- Nucor Corporation (NYSE: NUE) today announced guidance for its second quarter ending July 5, 2025. Nucor expects second quarter earnings to be in the range of $2.55 to $2.65 per diluted share. Nucor reported net earnings of $0.67 per diluted share in the first quarter of 2025 and $2.68 per diluted share in the second quarter of 2024.Second Quarter of 2025 CommentaryEarnings in the second quarter of 2025 are expected to increase across all three of our operating ...

Zefiro subsidiary P&G continues to work with government agencies as a trusted service provider for projects involving several aspects of environmental remediation.FORT LAUDERDALE, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that its wholly owned subsidiary, Plants & Goodwin, Inc. (“P&G”), has been selected as the prime contractor for a three-year Construction Manager at Risk (“CMA ...

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with Friedreich ataxia, a rare neurodegenerative disorderBRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA populationOmaveloxolone is currently marketed under the brand name SKYCLARYS® for the treatment of adults and adolescents aged 16 years and older affected by Friedreich ataxia CAMBRIDGE, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Bio ...

MONTREAL and LYON, France, June 18, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is proud to announce that its French technology partner, NOVACIUM SAS ("Novacium"), has launched the industrial production of cylindrical lithium-ion battery cells incorporating its third-generation silicon-based anode material ("GEN3"). Following the press releases dated Ju ...

Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer  FDA recommends inclusion of patients as young as 6 months – younger than Moleculin had proposed – to be allowed in the pediatric clinical study Enrollment and dosing are ongoing in pivotal, adaptive design Phase 3 MIRACLE trial of Annamycin in adult patients with R/R AML; Initial data readout is on track for the second half of 2025 HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculi ...